cGxP.wire https://validator.w3.org/feed/docs/rss2.html Neurocrine Initiates Phase 2 Trial of Crinecerfont in Children Under 4 with Classic CAH FDA Approves Tregzi for Chronic GVHD Prevention in Blood Cancer AlzeCure, QuantumCell Partner to Advance NeuroRestore ACD856 Median Technologies Expands AI Lung Cancer Screening in Europe United Therapeutics Expands Cell Therapy with Thymmune Deal Visby Medical Receives FDA Clearance for First Multi-Virus Home PCR Skyhawk Reports 12-Month Phase 1/2 Results for SKY-0515 Ribo, Madrigal Advance siRNA Therapy for MASH Treatment Nona, Lonza Partner on BBB Technology for CNS Therapies Trilogy Laboratories Acquires YNS Cosmeceuticals SkinSpirit Launches PDRN Salmon DNA Regenerative Treatment AdJane Validates OMV Vaccine Platform in Human Phase I Trial Cannabix Detects Methamphetamine in Human Breath Treos Bio Reports PolyPEPI1018 Immune Remodeling Data Tenax Therapeutics to Present LEVEL Phase 3 Data at ESC BridgeBio Reports Kidney Benefits With Attruby in ATTR-CM CSPC Pharma Secures Up to $1.77B AstraZeneca siRNA Deal Arcturus Therapeutics Partners With Thermo Fisher for ARCT-032 PolarityBio Submits FDA BLA for SkinTE in Diabetic Foot Ulcers VERAXA Partners with ATUM for BiTAC-TCE Development Newron Reports FDA Progress on Evenamide Phase 3 ENIGMA-TRS 2 Trial NKGen Biotech to Highlight Troculeucel Alzheimer’s Program at BIOCHINA Forum Revolution Medicines Reports Promising Phase 1/2 Zoldonrasib Combination Data in Metastatic Pancreatic Cancer Multitude Therapeutics Reports Positive AMT-676 Phase I Data Myriad Genetics Prolaris Study Validates Prostate Risk Test Endologix Reports 3-Year DETOUR2 Trial Success in PAD Insilico Secures Up to $600M Takeda AI Discovery Deal Oliva Therapeutics Launches Amerithroid for Hypothyroidism Abbisko and AstraZeneca Advance Oral PD-L1 Therapy for NSCLC GENFIT Secures U.S. Medicare Coverage for NASHnext Diagnostic Test AOB Pharma Partners Biorasi for Phase 2b Acne Trial Northwest Biotherapeutics to Present DCVax-L Survival Analysis at BNOS 2026 Arima Genomics Partners with Active Motif for Hi-C Research Distribution Mobia Medical Secures CMS Proposed 2027 Reimbursement for Vivistim Rosalind Franklin University Unveils New Infertility Research Telix Secures FDA Alignment to Advance ProstACT Phase 3 Trial Otsuka Advances VOYXACT Toward Traditional FDA Approval with Phase 3 Success Co-Diagnostics Completes Validation for FDA 510(k) Submission Hansa Biopharma Completes €115M Idefirix Licensing Deal Partner Therapeutics Reports JCO Results for BIZENGRI Partillion Bioscience Unveils New Framework for Cell Biology Arcus Biosciences Publishes Casdatifan Kidney Cancer Data 92Bio Doses First Patient in Phase 1 Trial of NTB-928 for Platinum-Resistant Ovarian Cancer Junshi Biosciences Expands Roconkibart Through Fosun Alliance Telum Therapeutics Raises €18M Series A for AMR Program Roche’s Divarasib Beats Approved KRAS Therapies in Phase III Trial Novartis Wins EU Approval for Itvisma® in Broad SMA Care MiDOG Launches First NGS Parasite Test for Veterinary Care ARTAN Bio Secures $1M Seed Round for tRNA Platform HUTCHMED Wins NMPA Approval for ORPATHYS® in Gastric Cancer